MALDI-TOF mass spectrometry from nucleic acid: development and evaluation of a novel platform for identification of mycobacteria and detection of genetic markers of resistance
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.01638-24 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Emily K DeCurtis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Diagnostics Laboratory, National Jewish Health, Denver, Colorado, USA. Hauptthemen laut MEDLINE: Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Nontuberculous Mycobacteria, Drug Resistance, Bacterial. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Jewish Health (NJH).
Abstract (Originalsprache)
Complete identification methods are critical for evaluating nontuberculous mycobacteria (NTM). Here, we describe a novel diagnostic method for identification of eight NTM, Mycobacterium tuberculosis complex, and three drug resistance markers using PCR/matrix-assisted, laser-desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) from cultured organisms. With this technology, a multiplex end-point PCR is performed for targets of interest. Detection probes that are extended in the presence of a target are added. The extended probes have greater molecular weight and can be detected by MALDI-TOF MS. An AFB Primary Panel was designed to differentiate Mycobacterium avium ; Mycobacterium intracellulare subsp. chimaera ; Mycobacterium avium complex (other); Mycobacterium abscessus subsp. abscessus , bolletii , and massiliense ; Mycobacterium kansasii , and M. tuberculosis complex. This design should cover 90% (3,483/3,691) of mycobacteria seen onsite. A development set of unblinded isolates ( n = 217) was used to develop PCR primers, detection probes, and probe barcodes. It demonstrated 99.1% (215/217) agreement with reference methods. An evaluation set using blinded isolates ( n = 320) showed an overall sensitivity of 94.3% (range by target: 90.0–100%). Overall specificity from negative media, non-target mycobacteria, and bacteria was 99.1% (108/109; range by target: 94.4–100%). Three drug resistance markers erm (41), rrl, and rrs demonstrated 100%, 91%, and 100% sensitivity, respectively, and >99% specificity. Limit of detection per target ranged from 2.2 × 10 3 to 9.9 × 10 6 CFU/mL. The AFB Primary Panel allows for mycobacterial speciation, subspeciation, and resistance mutation detection, which is essential for diagnosis, appropriate therapy, identifying outbreaks, and managing treatment-refractory disease. It can perform with high-throughput and high specificity and sensitivity from isolates. IMPORTANCE Even closely related mycobacteria can have unique treatment patterns, but differentiating these organisms is a challenge. Here, we tested an innovative platform that combines two commonly used technologies and creates something new: matrix-assisted, laser-desorption ionization time-of flight mass spectrometry was performed on PCR amplicons instead of on proteins. This created a robust system with the advantages of PCR (high discriminatory power, high throughput, detection of resistance) with the advantages of mass spectrometry (more targets, lower operational cost) in order to identify closely related mycobacterial organisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Advanced Diagnostics Laboratory, National Jewish Health, Denver, Colorado, USA.
- Department of Medicine, National Jewish Health, Denver, Colorado, USA.
ORCID-Profile: Reeti Khare
Förderung
- National Jewish Health (NJH)
Zitieren
APA
DeCurtis, E. K., Machado, I., Kuss-Duerkop, S. K., Wang, Y., & Khare, R. (2024). MALDI-TOF mass spectrometry from nucleic acid: development and evaluation of a novel platform for identification of mycobacteria and detection of genetic markers of resistance. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01638-24
Vancouver
DeCurtis EK, Machado I, Kuss-Duerkop SK, Wang Y, Khare R. MALDI-TOF mass spectrometry from nucleic acid: development and evaluation of a novel platform for identification of mycobacteria and detection of genetic markers of resistance. Microbiology Spectrum. 2024. doi:10.1128/spectrum.01638-24
BibTeX
@article{DeCurtis2024,
author = {DeCurtis, Emily K and Machado, Iara and Kuss-Duerkop, Sharon K and Wang, Yongbao and Khare, Reeti},
title = {MALDI-TOF mass spectrometry from nucleic acid: development and evaluation of a novel platform for identification of mycobacteria and detection of genetic markers of resistance},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.01638-24}
}
EUVIMED